Validation of Useful Markers Generated by Next Generation Bio-data Based Genome Research and Cohort Study (miRNA_Chip)
Multiple Biomarker Development Through Validation of Useful Markers Generated by Next Generation Bio-data Based Genome Research and Cohort Study
Sponsor: CHANGHEE LEE
A observational or N/A phase clinical study on BCL2 Gene mRNA Overexpression, this trial is completed. The trial is conducted by CHANGHEE LEE and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Feb 2020 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed
-
Oct 2018 — Feb 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CHANGHEE LEE
- LG Electronics Inc.
- Purdue University
For direct contact, visit the study record on ClinicalTrials.gov .